Literature DB >> 26271407

Raising the standard for clinical care of patients with Ebola virus disease.

John S Schieffelin1, Shevin T Jacob2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26271407     DOI： 10.1016/S1473-3099(15)00221-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Mathematical models for devising the optimal Ebola virus disease eradication.

Authors:  Shuo Jiang; Kaiqin Wang; Chaoqun Li; Guangbin Hong; Xuan Zhang; Menglin Shan; Hongbin Li; Jin Wang
Journal:  J Transl Med       Date:  2017-06-01       Impact factor: 5.531

2.  Research priorities during infectious disease emergencies in West Africa.

Authors:  Morenike Oluwatoyin Folayan; Bridget Haire; Dan Allman; Aminu Yakubu; Muhammed O Afolabi
Journal:  BMC Res Notes       Date:  2018-03-01

3.  Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak.

Authors:  Javier Arranz; Karen Marie Lundeby; Shoaib Hassan; Luis Matías Zabala Fuentes; Pedro San José Garcés; Yngvar Lunde Haaskjold; Håkon Angell Bolkan; Kurt Østhuus Krogh; James Jongopi; Sindre Mellesmo; Ola Jøsendal; Åsmund Øpstad; Erling Svensen; Alfred Sandy Kamara; David P Roberts; Paul D Stamper; Paula Austin; Alfredo J Moosa; Dennis Marke; Åse Berg; Bjørn Blomberg; Melcior Riera
Journal:  BMC Infect Dis       Date:  2016-06-22       Impact factor: 3.090

4.  Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.

Authors:  Tansy Edwards; Malcolm G Semple; Anja De Weggheleire; Yves Claeys; Maaike De Crop; Joris Menten; Raffaella Ravinetto; Sarah Temmerman; Lutgarde Lynen; Elhadj Ibrahima Bah; Peter G Smith; Johan van Griensven
Journal:  Clin Trials       Date:  2016-01-14       Impact factor: 2.486
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.